Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-24-032752
Filing Date
2024-08-16
Accepted
2024-08-16 08:57:27
Documents
1
Effectiveness Date
2024-08-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12536
  Complete submission text file 0001493152-24-032752.txt   13990
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-521729 | Film No.: 241214253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)